Privia Health Group, Inc. (NASDAQ:PRVA) Given Consensus Rating of “Buy” by Analysts

Shares of Privia Health Group, Inc. (NASDAQ:PRVA) have been given an average recommendation of “Buy” by the sixteen ratings firms that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $26.67.

PRVA has been the subject of a number of research analyst reports. JMP Securities set a $29.00 target price on Privia Health Group in a report on Friday, February 28th. Macquarie initiated coverage on Privia Health Group in a research report on Monday, December 16th. They issued an “outperform” rating and a $25.00 target price for the company. Needham & Company LLC reaffirmed a “buy” rating and set a $30.00 price target on shares of Privia Health Group in a report on Friday, March 21st. Stephens reissued an “overweight” rating and set a $26.00 price objective on shares of Privia Health Group in a report on Thursday, January 2nd. Finally, Piper Sandler raised their target price on shares of Privia Health Group from $25.00 to $40.00 and gave the stock an “overweight” rating in a report on Friday, February 28th.

Institutional Trading of Privia Health Group

Hedge funds and other institutional investors have recently bought and sold shares of the stock. First Horizon Advisors Inc. grew its stake in shares of Privia Health Group by 53.8% during the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock valued at $35,000 after acquiring an additional 632 shares during the period. EverSource Wealth Advisors LLC boosted its position in shares of Privia Health Group by 7,833.3% in the fourth quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock worth $47,000 after purchasing an additional 2,350 shares during the period. Financial Management Professionals Inc. purchased a new stake in shares of Privia Health Group in the fourth quarter worth $51,000. Quarry LP raised its position in shares of Privia Health Group by 344.6% during the 3rd quarter. Quarry LP now owns 3,268 shares of the company’s stock valued at $60,000 after purchasing an additional 2,533 shares during the period. Finally, KBC Group NV lifted its stake in shares of Privia Health Group by 34.6% during the 3rd quarter. KBC Group NV now owns 3,385 shares of the company’s stock valued at $62,000 after buying an additional 871 shares in the last quarter. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Privia Health Group Stock Down 1.4 %

Shares of PRVA opened at $22.59 on Monday. Privia Health Group has a twelve month low of $15.92 and a twelve month high of $26.04. The company has a market capitalization of $2.72 billion, a P/E ratio of 225.92, a price-to-earnings-growth ratio of 3.47 and a beta of 0.85. The firm has a 50 day moving average of $23.80 and a 200 day moving average of $21.20.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.